224 related articles for article (PubMed ID: 22144608)
1. Medicine. Personalized cancer diagnostics.
Corless CL
Science; 2011 Dec; 334(6060):1217-8. PubMed ID: 22144608
[No Abstract] [Full Text] [Related]
2. Support for the Human Cancer Genome Project.
Varmus H; Stillman B
Science; 2005 Dec; 310(5754):1615. PubMed ID: 16339428
[No Abstract] [Full Text] [Related]
3. [Cancer genome analysis through next-generation sequencing].
Aburatani H
Gan To Kagaku Ryoho; 2011 Jan; 38(1):1-6. PubMed ID: 21368453
[TBL] [Abstract][Full Text] [Related]
4. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
Liu X; Wang J; Chen L
Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
[TBL] [Abstract][Full Text] [Related]
5. From next-generation sequencing to nanopore sequencing technology: paving the way to personalized genomic medicine.
Ku CS; Roukos DH
Expert Rev Med Devices; 2013 Jan; 10(1):1-6. PubMed ID: 23278216
[No Abstract] [Full Text] [Related]
6. Deep sequencing in cancer research.
Yoshida K; Sanada M; Ogawa S
Jpn J Clin Oncol; 2013 Feb; 43(2):110-5. PubMed ID: 23225907
[TBL] [Abstract][Full Text] [Related]
7. Whole-genome and whole-exome sequencing in hereditary cancer: impact on genetic testing and counseling.
O'Daniel JM; Lee K
Cancer J; 2012; 18(4):287-92. PubMed ID: 22846728
[TBL] [Abstract][Full Text] [Related]
8. Clinical cancer genome and precision medicine.
Roukos DH; Ku CS
Ann Surg Oncol; 2012 Nov; 19(12):3646-50. PubMed ID: 22851046
[TBL] [Abstract][Full Text] [Related]
9. Exome sequencing: a transient technology for molecular diagnostics?
Ku CS; Cooper DN
Expert Rev Mol Diagn; 2012 Apr; 12(3):211-4. PubMed ID: 22468808
[No Abstract] [Full Text] [Related]
10. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
Roukos DH
Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
[TBL] [Abstract][Full Text] [Related]
11. [Genome sequencing for personalized cancer treatment].
Skotheim RI; Meza-Zepeda LA; Hovig E; Lønning PE; Lothe RA; Myklebost O
Tidsskr Nor Laegeforen; 2012 Nov; 132(21):2406-8. PubMed ID: 23160594
[No Abstract] [Full Text] [Related]
12. Whole genome and exome sequencing of melanoma: a step toward personalized targeted therapy.
Dutton-Regester K; Hayward NK
Adv Pharmacol; 2012; 65():399-435. PubMed ID: 22959033
[TBL] [Abstract][Full Text] [Related]
13. Challenges and opportunities for next-generation sequencing in companion diagnostics.
Lin E; Chien J; Ong FS; Fan JB
Expert Rev Mol Diagn; 2015 Feb; 15(2):193-209. PubMed ID: 25249308
[TBL] [Abstract][Full Text] [Related]
14. Cancer gene sequencing: ethical challenges and promises.
Devarakonda S; Govindan R; Hammerman PS
Virtual Mentor; 2012 Nov; 14(11):868-72. PubMed ID: 23351899
[No Abstract] [Full Text] [Related]
15. High-throughput sequencing set to enter patient care.
Hede K
J Natl Cancer Inst; 2012 Nov; 104(21):1620-1. PubMed ID: 23104214
[No Abstract] [Full Text] [Related]
16. Targeted high throughput sequencing of a cancer-related exome subset by specific sequence capture with a fully automated microarray platform.
Summerer D; Schracke N; Wu H; Cheng Y; Bau S; Stähler CF; Stähler PF; Beier M
Genomics; 2010 Apr; 95(4):241-6. PubMed ID: 20138981
[TBL] [Abstract][Full Text] [Related]
17. Personalized medicine.
Shute N
Sci Am; 2012 May; 306(5):44. PubMed ID: 22550921
[No Abstract] [Full Text] [Related]
18. National Institutes of Health. NCI gears up for cancer genome project.
Kaiser J
Science; 2005 Feb; 307(5713):1182. PubMed ID: 15731412
[No Abstract] [Full Text] [Related]
19. [Critical parameters in clinical sequencing].
Jordan B
Med Sci (Paris); 2012 Jan; 28(1):109-11. PubMed ID: 22289839
[No Abstract] [Full Text] [Related]
20. Genomics and epigenomics: new promises of personalized medicine for cancer patients.
Schweiger MR; Barmeyer C; Timmermann B
Brief Funct Genomics; 2013 Sep; 12(5):411-21. PubMed ID: 23814132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
